Publications

(2026). Estimands and their implications for evidence synthesis for oncology: A simulation study of treatment switching in meta-analysis. 17(1), Research Synthesis Methods.
(2025). Marginal and Conditional Summary Measures: Transportability and Compatibility Across Studies. In Wiley StatsRef: Statistics Reference Online.
(2025). Can Estimands Support Aligned Evidence Generation for EU HTA? Reflections on Their Role in Joint Clinical Assessments, PICO Alignment, and Beyond. In Value in Health, 28(12).
(2025). Incorporating estimands into meta-analyses of clinical trials.
(2025). Population-Adjusted Indirect Comparisons. In R for Health Technology Assessment.
(2025). The Importance of Specifying the Estimand in Meta-Analyses in the Presence of Treatment Switching. In Value in Health, 28(6).
(2025). Effect modification and non-collapsibility together may lead to conflicting treatment decisions: A review of marginal and conditional estimands and recommendations for decision-making. Research Synthesis Methods, 16(2).
(2024). Treatment Switching in Evidence Synthesis in Oncology: A Comprehensive Review of Current Meta-Analytical Practices. In Value in Health, 27(12).